Patient clinical data and proportions of spleen pDCs and mDCs
| Patient . | HIV infection . | pDCs/mDCs, % . | CD4/mm3 . | Clinical data . | Treatment at splenectomy . |
|---|---|---|---|---|---|
| A | No | 0.27/0.47 | — | ITP | Corticoids |
| B | No | 0.23/0.13 | — | Splenomegaly, angioma | — |
| C | No | 0.22/0.20 | — | Pancreatic adenocarcinoma | — |
| D | No | 0.03/0.07 | — | ITP, autoimmune hemolytic anemia, myelodysplasy, extramedullary splenic hematopoiesis | — |
| E | No | 0.11/0.17 | — | Evans syndrome (ITP + hemolytic anemia), toxic hepatitis | Immunoglobulins |
| F | No | 0.04/0.05 | — | Rheumatoid arthritis, renal cancer with metastasis | Corticoids |
| G | No | 0.27/0.16 | — | ITP | Immunoglobulins |
| H | No | 0.15/0.17 | — | Pancreatic adenocarcinoma, metastasis from lung epidermoid carcinoma | — |
| I | No | 0.26/0.06 | — | Neuroendrocrine pancreatic tumor with lymph node metastasis | — |
| J | No | 0.7/0.06 | — | Pancreatic adenocarcinoma, Wirsung duct obstruction with pancreatitis | — |
| K | No | — | — | Hemolytic anemia | — |
| L | No | — | — | ITP | — |
| M | Yes | 0.21/0.1 | 474 | ITP, chronic HBV hepatitis, EBV infection | HAART |
| N | Yes | 0.03/0.01 | 3 | ITP, hemophagocytosis, CMV infection, former cryptococcosis, mycosis | HAART, Foscarnet, rituximab, corticoids, immunoglobulins |
| O | Yes | 0.32/0.12 | 400 | ITP | HAART |
| P | Yes | — | 178 | ITP, Kaposi | HAART, Vinblastine |
| Q | Yes | 0.82/0.06 | 110 | ITP, hemophagocytosis, HBV hepatitis, salmonellosis, fever, asthenia, anorexia, weight loss | No HAART |
| R | Yes | — | 94 | ITP | No HAART |
| S | Yes | 1.17/0.06 | 312 | ITP, pre-Castleman syndrome | AZT, No HAART |
| Patient . | HIV infection . | pDCs/mDCs, % . | CD4/mm3 . | Clinical data . | Treatment at splenectomy . |
|---|---|---|---|---|---|
| A | No | 0.27/0.47 | — | ITP | Corticoids |
| B | No | 0.23/0.13 | — | Splenomegaly, angioma | — |
| C | No | 0.22/0.20 | — | Pancreatic adenocarcinoma | — |
| D | No | 0.03/0.07 | — | ITP, autoimmune hemolytic anemia, myelodysplasy, extramedullary splenic hematopoiesis | — |
| E | No | 0.11/0.17 | — | Evans syndrome (ITP + hemolytic anemia), toxic hepatitis | Immunoglobulins |
| F | No | 0.04/0.05 | — | Rheumatoid arthritis, renal cancer with metastasis | Corticoids |
| G | No | 0.27/0.16 | — | ITP | Immunoglobulins |
| H | No | 0.15/0.17 | — | Pancreatic adenocarcinoma, metastasis from lung epidermoid carcinoma | — |
| I | No | 0.26/0.06 | — | Neuroendrocrine pancreatic tumor with lymph node metastasis | — |
| J | No | 0.7/0.06 | — | Pancreatic adenocarcinoma, Wirsung duct obstruction with pancreatitis | — |
| K | No | — | — | Hemolytic anemia | — |
| L | No | — | — | ITP | — |
| M | Yes | 0.21/0.1 | 474 | ITP, chronic HBV hepatitis, EBV infection | HAART |
| N | Yes | 0.03/0.01 | 3 | ITP, hemophagocytosis, CMV infection, former cryptococcosis, mycosis | HAART, Foscarnet, rituximab, corticoids, immunoglobulins |
| O | Yes | 0.32/0.12 | 400 | ITP | HAART |
| P | Yes | — | 178 | ITP, Kaposi | HAART, Vinblastine |
| Q | Yes | 0.82/0.06 | 110 | ITP, hemophagocytosis, HBV hepatitis, salmonellosis, fever, asthenia, anorexia, weight loss | No HAART |
| R | Yes | — | 94 | ITP | No HAART |
| S | Yes | 1.17/0.06 | 312 | ITP, pre-Castleman syndrome | AZT, No HAART |
— indicates not applicable; AZT, zidovudine; CMV, cytomegalovirus; EBV, Epstein-Barr virus; and HBV, hepatitis B virus.